Spero Therapeutics (SPRO) Amortizatization of Intangibles (2018 - 2022)
Spero Therapeutics posted quarterly Amortizatization of Intangibles of $10000.0 for Q2 2022, up 116.67% year-on-year from $4615.4 in Q2 2021, and up 143.48% on a QoQ basis from -$23000.0 in Q1 2022.
Spero Therapeutics (SPRO) has 5 years of Amortizatization of Intangibles data on file, last reported at $10000.0 in Q2 2022.
- For the quarter ending Q2 2022, Amortizatization of Intangibles rose 116.67% year-over-year to $10000.0; the trailing twelve-month figure through Mar 2023 stood at $10000.0 (up 104.76% YoY), and the FY2022 full-year result was -$13000.0, up 94.82% from the prior year.
- Amortizatization of Intangibles for Q2 2022 stood at $10000.0, up from -$23000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $355000.0 in Q1 2019 and bottomed at -$73000.0 in Q3 2021.
- The 5-year median for Amortizatization of Intangibles is $27500.0 (2018), against an average of $66055.6.
- The widest annual swing landed in 2019, when Amortizatization of Intangibles surged 688.89%; it then sank 3550.0% in 2021.
- A 5-year view of Amortizatization of Intangibles shows it stood at $325000.0 in 2018, then plunged by 73.23% to $87000.0 in 2019, then sank by 128.74% to -$25000.0 in 2020, then sank by 116.0% to -$54000.0 in 2021, then jumped by 118.52% to $10000.0 in 2022.
- The last three Amortizatization of Intangibles figures came in at $10000.0 (Q2 2022), -$23000.0 (Q1 2022), and -$54000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | -73,000.00 |
| Sep 30, 2021 | -73,000.00 |
| Jun 30, 2021 | -60,000.00 |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -64,000.00 |
| Mar 31, 2021 | -64,000.00 |
| Dec 31, 2020 | -25,000.00 |
| Dec 31, 2020 | -25,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 53,000.00 |
| Mar 31, 2020 | 53,000.00 |
| Dec 31, 2019 | 87,000.00 |
| Dec 31, 2019 | 87,000.00 |
| Sep 30, 2019 | 102,000.00 |
| Sep 30, 2019 | 102,000.00 |
| Jun 30, 2019 | 206,000.00 |
| Jun 30, 2019 | 206,000.00 |
| Mar 31, 2019 | 355,000.00 |
| Mar 31, 2019 | 355,000.00 |
| Dec 31, 2018 | 325,000.00 |
| Dec 31, 2018 | 325,000.00 |
| Sep 30, 2018 | 234,000.00 |
| Sep 30, 2018 | 234,000.00 |
| Jun 30, 2018 | 67,000.00 |
| Jun 30, 2018 | 67,000.00 |
| Mar 31, 2018 | 45,000.00 |
| Mar 31, 2018 | 45,000.00 |